Table 3.

Treatment targets and possible options for patients with HBV/HIV co-infection.

Co-infection target	Treatment option
Hepatitis B virus (HBeAg+)	interferon-a (pegylated); entecavir; or Adefovir
Hepatitis B virus (HBeAg−)	Interferon-a (pegylated); Entecavir; Adefovir
Hepatitis B virus and HIV	antiretroviral (HIV) regimen, including lamivudine or emtricitabine with tenofovir or adefovir
To control HIV	antiretroviral (HIV) regimen + adefovir or entecavir antiretroviral (HIV) regimen + one HBV antiviral drug to avoid immune reconstitution induced liver disease